北美生物制药合同制造市场预测至 2028 年 - COVID-19 影响和按产品（生物制品和生物仿制药）、服务（工艺开发、灌装和完成操作、分析和质量控制研究以及包装）和来源（哺乳动物和微生物）进行的区域分析-基于生物制剂/非哺乳动物）
No. of Pages: 130 | Report Code: TIPRE00010242 | Category: Life Sciences
No. of Pages: 130 | Report Code: TIPRE00010242 | Category: Life Sciences
合同制造组织 (CMO) 提供给制药公司带来许多好处，包括减少设施投资和药物开发成本，从而改善净现金流。外包成本更低，并且提高了制造流程的效率。它允许制药和生物技术公司将资源转向其他领域。在过去的几年里，合同制造行业是一个利基服务市场，为制药公司提供更多的制造能力或特定服务。药品生产失败数量的增加推动了 CMO 的兴起。制药公司过去承担了许多生产设施来开发创新药物。然而，制造外包需求不断上升，以降低产能过剩风险。此外，一些制药公司正在重新关注其核心能力，例如研发，导致内部制造能力的剥离，进一步增加了对 CMOS 制造的依赖。此外，CMO 通过为制药公司提供具有多地点供应策略和备用能力的多个地点，在提供额外好处以减轻供应短缺风险方面发挥着至关重要的作用。例如，2019年，三星生物制品公司与GI Innovation公司签署了免疫化疗合同。根据该协议，三星生物制品公司提供从 f 细胞系开发到 I 期原料药生产的服务。因此，越来越多的开发、制造、灌装和包装业务外包给合同制造公司，预计将为市场参与者创造巨大的市场机会，从而带动生物制药合同制造市场的后续增长。
Strategic insights for North America Biopharmaceutical Contract Manufacturing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 7,127.97 Million |
| Market Size by 2028 | US$ 12,847.38 Million |
| Global CAGR (2021 - 2028) | 8.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Biopharmaceutical Contract Manufacturing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Biopharmaceutical Contract Manufacturing Market is valued at US$ 7,127.97 Million in 2021, it is projected to reach US$ 12,847.38 Million by 2028.
As per our report North America Biopharmaceutical Contract Manufacturing Market, the market size is valued at US$ 7,127.97 Million in 2021, projecting it to reach US$ 12,847.38 Million by 2028. This translates to a CAGR of approximately 8.8% during the forecast period.
The North America Biopharmaceutical Contract Manufacturing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Biopharmaceutical Contract Manufacturing Market report:
The North America Biopharmaceutical Contract Manufacturing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Biopharmaceutical Contract Manufacturing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Biopharmaceutical Contract Manufacturing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Biopharmaceutical Contract Manufacturing Market
